FI53593C - Foerfarande foer framstaellning av calici-virusvaccin - Google Patents

Foerfarande foer framstaellning av calici-virusvaccin

Info

Publication number
FI53593C
FI53593C FI753274A FI753274A FI53593C FI 53593 C FI53593 C FI 53593C FI 753274 A FI753274 A FI 753274A FI 753274 A FI753274 A FI 753274A FI 53593 C FI53593 C FI 53593C
Authority
FI
Finland
Prior art keywords
calici
virus vaccines
frequency fragmentation
fragmentation
frequency
Prior art date
Application number
FI753274A
Other languages
English (en)
Finnish (fi)
Other versions
FI53593B (fr
FI753274A (fr
Inventor
James Long Bittle
Wayne J Rubic
Original Assignee
Pitman Moore Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pitman Moore Inc filed Critical Pitman Moore Inc
Publication of FI753274A publication Critical patent/FI753274A/fi
Application granted granted Critical
Publication of FI53593B publication Critical patent/FI53593B/fi
Publication of FI53593C publication Critical patent/FI53593C/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/125Picornaviridae, e.g. calicivirus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5254Virus avirulent or attenuated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/16011Caliciviridae
    • C12N2770/16034Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00Drug, bio-affecting and body treating compositions
    • Y10S424/819Viral vaccine for feline species, e.g. cats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FI753274A 1974-11-21 1975-11-20 Foerfarande foer framstaellning av calici-virusvaccin FI53593C (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/525,689 US3944469A (en) 1974-11-21 1974-11-21 Feline calicivirus vaccine and production thereof

Publications (3)

Publication Number Publication Date
FI753274A FI753274A (fr) 1976-05-22
FI53593B FI53593B (fr) 1978-02-28
FI53593C true FI53593C (fi) 1978-06-12

Family

ID=24094242

Family Applications (1)

Application Number Title Priority Date Filing Date
FI753274A FI53593C (fi) 1974-11-21 1975-11-20 Foerfarande foer framstaellning av calici-virusvaccin

Country Status (17)

Country Link
US (1) US3944469A (fr)
JP (1) JPS5173118A (fr)
AT (1) AT340584B (fr)
AU (1) AU508944B2 (fr)
BE (1) BE835784A (fr)
CA (1) CA1055844A (fr)
CH (1) CH622702A5 (fr)
DE (1) DE2552137A1 (fr)
DK (1) DK141339B (fr)
ES (1) ES442892A1 (fr)
FI (1) FI53593C (fr)
FR (1) FR2291766A1 (fr)
GB (1) GB1522006A (fr)
NL (1) NL7513644A (fr)
NO (1) NO753676L (fr)
SE (1) SE7512828L (fr)
ZA (1) ZA757294B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4287178A (en) * 1974-03-25 1981-09-01 Pitman-Moore, Inc. Feline rhinotracheitis vaccine and production and use thereof
ES8107025A1 (es) * 1978-11-30 1980-12-16 Wellcome Found Un metodo de preparar una vacuna que contiene una cepa ate- nuada de virus de peritonitis infecciosa felina.
US4303644A (en) * 1979-10-16 1981-12-01 Norden Laboratories, Inc. Feline infectious peritonitis virus vaccines
US4303645A (en) * 1980-04-18 1981-12-01 Cornell Research Foundation, Inc. Modified living canine parvovirus vaccine
US4537769A (en) * 1982-04-06 1985-08-27 American Cyanamid Company Stabilization of influenza virus vaccine
US4522810A (en) * 1982-12-09 1985-06-11 The Regents Of The University Of California Feline calicivirus vaccine
US5374424A (en) * 1986-10-03 1994-12-20 Miles Inc. Multivalent felv-infected feline vaccine
CA2090515C (fr) * 1992-02-28 2002-10-29 Kazuhiko Kimachi Anticorps recombinant dirige contre le calicivirus felin et fragment de gene codant ledit anticorps
US6355246B1 (en) 1999-06-10 2002-03-12 Board Of Trustees Of Michigan State University Feline calicivirus isolated from cat urine and vaccines thereof
US7309495B2 (en) * 2003-03-14 2007-12-18 The Regents Of The University Of California Hemorrhagic feline calicivirus
CA2513458C (fr) * 2003-03-14 2013-01-22 The Regents Of The University Of California Calicivirus felin systemique virulent
US7306807B2 (en) 2004-09-13 2007-12-11 Wyeth Hemorrhagic feline calicivirus, calicivirus vaccine and method for preventing calicivirus infection or disease
MX2008001326A (es) 2005-07-28 2008-03-19 Pfizer Prod Inc Procedimientos de administracion de vacunas, nuevos calicivirus felinos, y tratamientos para inmunizar animales contra paraovirus felino y herpes virus felino.
WO2008150404A1 (fr) * 2007-05-30 2008-12-11 Wyeth Poxvirus du raton laveur exprimant les gènes des antigènes félins
EP3389706A1 (fr) 2015-12-14 2018-10-24 Boehringer Ingelheim Vetmedica, Inc. Vaccins pour félins à noyaux hybrides
CN114874997B (zh) * 2022-05-26 2023-05-23 中国农业科学院哈尔滨兽医研究所(中国动物卫生与流行病学中心哈尔滨分中心) 猫杯状病毒

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1177635A (en) * 1966-02-18 1970-01-14 Wellcome Found Cell Stains.

Also Published As

Publication number Publication date
ES442892A1 (es) 1977-08-16
BE835784A (fr) 1976-05-20
SE7512828L (sv) 1976-05-24
US3944469A (en) 1976-03-16
DK141339C (fr) 1980-08-25
DK141339B (da) 1980-02-25
AT340584B (de) 1977-12-27
JPS5173118A (fr) 1976-06-24
ATA884975A (de) 1977-04-15
FI53593B (fr) 1978-02-28
DE2552137A1 (de) 1976-05-26
NO753676L (fr) 1976-05-24
AU508944B2 (en) 1980-04-17
AU8675575A (en) 1977-05-26
FR2291766A1 (fr) 1976-06-18
NL7513644A (nl) 1976-05-25
FR2291766B1 (fr) 1978-07-28
FI753274A (fr) 1976-05-22
ZA757294B (en) 1977-06-29
GB1522006A (en) 1978-08-23
CH622702A5 (fr) 1981-04-30
CA1055844A (en) 1979-06-05
DK516975A (fr) 1976-05-22

Similar Documents

Publication Publication Date Title
FI53718C (fi) Foerfarande foer framstaellning av antibiotikumet tienamycin
FI53593C (fi) Foerfarande foer framstaellning av calici-virusvaccin
SE415379B (sv) Isolerande flerglasruta och framstellning herav
SE7513085L (sv) Forfarande for framstellning av etrar
TR19139A (tr) Laktatdehidrojenazenin izoenzimlerinin hepbirden tesbitine mahsus usul
IT1044002B (it) Stabilizzazione di xantofille
FI55851C (fi) Foerfarande foer framstaellning av antiandrogeniskt verksamma 16-dehydro-androstanderivat
SE7509534L (sv) Isokinolinforeningar och forfarande for framstellning derav
SE7506160L (sv) Forfarande for framstellning av n-cykloalkylmetyldekahydroisokinoline
SE425790B (sv) Forfarande for framstellning av polylaurinlactam
SE7511438L (sv) 7-hydroxi-ostradioler och sett att framstella desamma
SE7509909L (sv) Isolerat plastror och forfarande for tillverkning derav
SE7511931L (sv) Penicilliner och forfarande for framstellning derav
SE411453B (sv) Forfarande for framstellning av 3-fluorcefalosporiner
SE7513302L (sv) Framstellning av etrar
SE426827B (sv) Nytt forfarande for framstellning av 7beta-acylamino-7alfa-alkoxicefalosporiner
JPS56127319A (en) Manufacture of influenza vaccine
SE7513879L (sv) Forfarande for syntes av karbamider
SE7511801L (sv) Forfarande for framstellning av ympsampolymerisat
IT1035885B (it) Divisore di frequenza
IT1028363B (it) Miscele di polieteri
SE7509569L (sv) Framstellning av etrar
SE7510782L (sv) Forfarande och anordning for framstellning av strengformiga foremal
IT1037092B (it) Tetraidopiranil eteri di estrugeni
SE420097B (sv) Forfarande for framstellning av hydroxialkylxantiner

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: PITMAN-MOORE INC.